Abstract
A series of 532 women with genital HPV infections has been prospectively followed-up without treatment since 1981 for a mean of 50 (+/-21) months. The patients were examined at six month intervals by colposcopy, PAP smears and/or biopsy. HPV typing of all biopsies was completed using in situ, Southern blot and/or sandwich hybridization with DNA probes for types 6, 11, 16, 18, 31 and 33. Survival data analysis was applied to analyse the clinical course (i.e. spontaneous regression and progression) of the HPV lesions stratified by their HPV type, currently available for 458 women. Clinical progression was significantly related to the HPV type present in the lesions. The progression rate was 11.1% (6/54) for HPV 6 lesions, 14.3% (8/ 56) for HPV 11, 35.2% (32/91) for HPV 16,12.5% (4/32) for HPV 18,18.8% (6/32) for HPV 31,19.4% (6/31) for HPV 33 and 28.6% (4/14) for doubly infected lesions. The lowest progression rate, 6.1% (9/ 148), was found in lesions which remained constantly HPV DNA-negative. In the survival analysis the probability of progression varied significantly between the six HPV types (p=0.0005, overall). After grouping the viral types as HPV 6/11 (‘low risk’), HPV 16/18 (‘high risk’) and HPV 31/33 (‘intermediate risk’) the overall probability of progression remained significantly different (p=0.0035, overall). In clinical regression, however, the HPV type was not an equally good predictor (p=0.1952, overall). Within groups HPV 6/11, 16/18 and 31/33 the differences were even less significant (p= 0.4759, overall). In the pairwise comparison significant differences in progression occurred when HPV type 16 was compared to HPV 6, HPV 11 or HPV DNA-negative lesions. In regression similar differences existed in comparison of HPV DNA-negative to HPV 6 or HPV 18 lesions.
These data confirm the previous finding of HPV type 16 as a ‘high risk’ type in cervical infections. Types 31 and 33 belong to ‘intermediate’ category. Although, previously included in the ‘high risk’ category, type 18 did not markedly differ from the clinical course of the ‘low risk’ (HPV 6, 11) types in the study.
Similar content being viewed by others
References
Boshard, M. et al. (1984): A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. - EMBO J. 3: 1151–1157
Campion, M. et al. (1986): Progressive potential of mild cervical atypia: prospective cytological, colposcopic and virological study. - Lancet ii: 237–238.
Costa, S. et al. (1988): Intramuscular Beta-interferon treatment of human papillomavirus lesions in the lower female genital tract. - Cervix & 1.f.g.t. 6: 203–212.
Cox, M.F. et al. (1986): Human papillomavirus type 16 homologous DNA in normal human ectocervix. -Lancet ii: 157.
Demeter, T. et al. (1987): Detection of DNA of human papillomavirus types 6/11 and 16/18 in cell scrapings of the uterine cervix by filter in situ hybridization. Correlation with cytology, colposcopy and histology.- Eur. J. Epidemiol. 3: 404–413.
Durst, M. et al. (1983): A papilloamavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. -Proc. Natl. Acad. Sci. USA 80: 3812–3814.
Evans, A.S. et al. (1985): Spontaneous resolution of cervical warty atypia: the relevance of clinical and nuclear DNA features: a prospective study. - Br. J. Obstetr. Gyn. 92: 165–169.
Grunebaum, [itA.N. et al. (1983): Association of human papillomavirus infection with cervical intraepithelial neoplasia. - Obstet. Gynecol. 62: 448.
Kadish, A.S. et al. (1986): Human papillomavirus of different types in precancerous lesions of the uterine cervix: histologic, immunohistochemical and ultrastrucutural studies. - Hum. Pathol. 17: 384–392.
Kaplan, E.C. et al. (1958): Nonparametric estimation from incomplete observations. - J. Am. Statist. Ass. 53: 457–481.
Kataja V. et al. (1989): Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. -Eur. J. Epidemiol. In press.
Koss, L. G. (1987): Citologic and histologic manifestations of human papillomavirus infection of the female genital tract and their clinical significance.- Cancer 60: 1942–1950.
Kulski, J. K. et al. (1987): DNA sequences of human papillomavirus types 11, 16 and 18 in invasive cervical carcinoma of Western Australian women. -Immunol. Cell Biol. 65: 77–84.
Lee, E. T. (1984): Statistical methods for survival data analysis. Life Time Learning Publications, Belmont, California, pp. 9–156.
Macnab, J. C. M. et al.(1986): Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. - New Engl. J. Med. 315: 1052.
Meanwell, C.A. (1987): HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behavior of cervical neoplasia. - Lancet i: 703.
Mitchell, H. et al. (1986): Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection. - Lancet i: 573–575.
Munoz, N., Bosch, X. and Kaldor, J.M. (1988): Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. - Br. J. Cancer 57: 1–5.
Nasiell, K. et al. (1986): Behavior of mild cervical dysplasia during long term follow-up. Obstet. & Gynecol. 67: 665–669.
Okagaki, T. (1984): Female genital tumors associated with human papillomavirus infection and the concept of genital neoplasm-papilloma syndrome (GENPS). Pathol. Annu. 19: 31.
Peto, R. et al. (1977): Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and examples. - Br. J. Cancer 35: 1–39.
Reeves, W.C. et al. (1987): Case-control study of human papillomaviruses and cervical cancer in Latin America. - Int. J. Cancer 40: 450.
Robertson, J.H. et al. (1988): Risk of cervical cancer associated with mild dyskaryosis. - BMJ 297: 18–21.
Schneider, A. et al. (1987): Human papillomavirus in women with a history of abnormal papanicolaou smears and in their male partners. - Obstet. Gynecol. 69: 554.
SPSS-X Users Guide (1983): McGraw-Hill Book Company, New York, 1983, pp. 96–104.
Syrjanen, K.J. (1983): Human papillomavirus (HPV) lesions in association with cervical dysplasia and neoplasms. - Obstet Gynecol. 62: 617–624.
Syrjanen, K. et al. (1985): Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix. -Eur. J. Epidemiol. 1: 180–187.
Syrjänen, K. et al. (1985): Natural history of HPV infections in uterine cervix as determined by prospective follow-up. In: P.M. Howley and T.R. Broker (eds) Papilloma viruses: Molecular and clinical aspects, UCLA Symposia on Molecular and Cellular Biology, Alan R. Liss, Inc., New York. - New Series 32: 31–45.
Syrjänen, K. et al. (1985): Cervical papillomavirus infections progressing to invasive cancer in less than three years. - Lancet i:510–511.
Syrjänen, K. et al. (1987): Assessing the biological potential of human papillomavirus infections in cervical carcinogenesis. - Cancer Cells 5 281–289.
Syrjänen, K.J.(1987):Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. - Med. Biol. 65:21–39.
Syrjänen, K. et al. (1988): Factors associated with progression of cervical Human papillomavirus (HPV) infections during a long-term prospective follow-up. Brit. J. Obstet. Gynaecol. 95: 1096–1102.
Syrjänen K. et al. (1988): Prevalence, incidence and estimated life-time risk of cervical human papillomavirus (HPV) infections in nonselected Finnish female population. — Sex. Transm. Dis. Submitted.
Syrjanen, S., Syrjanen, K. (1986): An improved in situ DNA hybridization protocol for detection of human papillomavirus (HPV) DNA sequences in paraffin-embedded biopsies. - J. Virol. Methods 14: 293–304.
Syrjanen, S. et al. (1988): Sensitivity of in situ hydridization techniques using biotin- and 35-Slabelled human papillomavirus (HPV) DNA probes. -J. Virol. Methods 19: 225–228.
Väyrynen, M. (1986): Natural history of cervical HPV infections. Colposcopic assessment and biological considerations. Publications of the University of Kuopio, Orig. Rep. 2: 1–83.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Kataja, V., Syrjänen, K., Syrjanen, S. et al. Prospective follow-up of genital HPV infections: Survival analysis of the HPV typing data. Eur J Epidemiol 6, 9–14 (1990). https://doi.org/10.1007/BF00155542
Issue Date:
DOI: https://doi.org/10.1007/BF00155542